EL
ABBV icon

Essex LLC’s AbbVie ABBV Stock Holding History

Essex LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$751K Sell
2,984
-249
-8% -$53.6K 0.11% 97
2026
Q1 		$703K Sell
3,233
-2,394
-43% -$531K 0.12% 96
2025
Q4 		$1.29M Buy
5,627
+1,060
+23% +$241K 0.23% 76
2025
Q3 		$1.06M Buy
4,567
+588
+15% +$120K 0.19% 84
2025
Q2 		$739K Buy
3,979
+1,429
+56% +$266K 0.15% 98
2025
Q1 		$534K Sell
2,550
-37
-1% -$7.19K 0.12% 98
2024
Q4 		$460K Buy
2,587
+2
+0.1% +$368 0.1% 106
2024
Q3 		$510K Sell
2,585
-137
-5% -$25.6K 0.1% 107
2024
Q2 		$467K Buy
2,722
+2
+0.1% +$331 0.1% 105
2024
Q1 		$495K Sell
2,720
-96
-3% -$16.5K 0.11% 102
2023
Q4 		$436K Sell
2,816
-483
-15% -$70.4K 0.11% 109
2023
Q3 		$492K Buy
3,299
+39
+1% +$5.72K 0.14% 101
2023
Q2 		$439K Sell
3,260
-673
-17% -$98.7K 0.12% 101
2023
Q1 		$636K Hold
3,933
– – 0.19% 95
2022
Q4 		$636K Buy
3,933
+94
+2% +$14.4K 0.19% 95
2022
Q3 		$515K Sell
3,839
-74
-2% -$10.6K 0.17% 97
2022
Q2 		$599K Sell
3,913
-119
-3% -$18.2K 0.19% 98
2022
Q1 		$654K Sell
4,032
-399
-9% -$58K 0.18% 100
2021
Q4 		$600K Sell
4,431
-19
-0.4% -$2.24K 0.16% 108
2021
Q3 		$480K Buy
+4,450
New +$508K 0.13% 116

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Essex LLC's ABBV Position: Q2 2026 in Review

Essex LLC reduced its AbbVie (ABBV) stake by 7.7% in Q2 2026, selling an estimated $53.6K and leaving 2,984 shares worth $751K. The position accounts for 0.11% of the portfolio, ranked #97.

Essex LLC first reported a position in ABBV in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.29M in Q4 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Essex LLC held 2,984 shares of AbbVie worth $751K as of Q2 2026.
  • Essex LLC sold 249 AbbVie shares in Q2 2026, an estimated $53.6K.
  • AbbVie made up 0.11% of Essex LLC's portfolio in Q2 2026, its #97 holding.
  • Essex LLC first reported a position in AbbVie in Q3 2021 and has held it in 20 quarters since.
  • Essex LLC's AbbVie position peaked at $1.29M in Q4 2025.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Essex LLC's 13F filing for Q2 2026, filed 24 Jul 2026.